Drop Test Failure after valve supplier change: packaging integrity and transport risk assessment






Published on 30/12/2025

Assessing Drop Test Failures Following a Change in Valve Supplier: A Comprehensive Investigation

In the highly regulated world of pharmaceutical manufacturing, deviations and failures can pose serious risks to product integrity and patient safety. A recent case involving a drop test failure after a change in valve suppliers raised concerns about packaging integrity and transport risks. This article will guide you through a systematic investigation approach, helping to ensure compliance with FDA, EMA, and MHRA standards while implementing effective CAPA strategies.

After reading this article, you will be equipped to identify symptoms of failure, potential causes, immediate containment actions, and a comprehensive investigation workflow necessary for addressing drop test failures effectively.

Symptoms/Signals on the Floor or in the Lab

Drop test failures can manifest in various ways, leading to significant operational challenges. Symptoms may include:

  • Increased number of complaints regarding packaging integrity from internal quality checks or external customers.
  • Physical damage to the packaging observed during normal operations or following
transport simulations.
  • Documented deviations within production logs, particularly in post-production testing.
  • Visual inspections revealing leaks or compromised seals.
  • Monitoring these symptoms is crucial for early detection. Quality Control (QC) teams should maintain strict records of any anomalies during evaluations and correlate findings with recent changes to supplier or materials.

    Explore the full topic: Aerosol Formulations

    Likely Causes (by category: Materials, Method, Machine, Man, Measurement, Environment)

    Understanding the root causes of drop test failures following a valve supplier change involves examining various categories that could contribute to these irregularities:

    Category Potential Causes
    Materials Differences in valve material composition resulting in variations in sealing quality.
    Method Incompatibilities in or deviations from established drop test methodologies.
    Machine Calibrations or settings on filling and packaging equipment that might not align with new valve specifications.
    Man Training gaps for personnel on the handling of new valve components or procedures.
    Measurement Lack of validated measurement tools or methods to assess valve performance under stress.
    Environment Changes in ambient conditions affecting material performance during testing.

    Each of these categories requires investigation to effectively address the failure at hand.

    Immediate Containment Actions (first 60 minutes)

    When a drop test failure is identified, immediate containment actions are critical to minimize risks:

    1. Quarantine affected batches: Secure any batches that have passed through the implicated production line or used the new valve supplier until investigations are concluded.
    2. Notify stakeholders: Alert relevant internal departments including QA, QC, and Regulatory Affairs, as well as any external stakeholders if necessary.
    3. Review batch records: Scrutinize the batch production records for the affected batches to understand the extent of the issue.
    4. Implement temporary testing procedures: Increase the frequency of drop tests on additional batches to determine the prevalence of the failure across production.
    5. Reassess the supply chain: Review the supplier’s change documentation, including qualification reports, and check any procurement-related deviations.

    Effective communication during this phase can help to align cross-functional teams on immediate priorities.

    Investigation Workflow (data to collect + how to interpret)

    After containment actions, a well-defined investigation workflow is essential:

    • Data Collection: Gather all relevant documentation, including batch records, testing logs, materials data sheets (MDS), supplier certifications, and deviation reports.
    • Root Cause Analysis: Utilize structured tools like 5-Why and Fishbone diagrams to analyze the data collected. This can provide insight into primary causative factors as well as secondary contributing influences.
    • Environmental Assessment: Ensure that environmental monitoring records are reviewed, particularly if changes in temperature, humidity, or handling protocols occurred during or after the valve change.

    Documentation gathered during the workflow will also serve as vital evidence for regulatory inspections and internal reviews.

    Root Cause Tools (5-Why, Fishbone, Fault Tree) and when to use which

    Selecting the appropriate root cause analysis tool will enhance the efficiency of your investigation:

    • 5-Why Analysis: Best used for straightforward issues where the cause is not immediately evident. This method encourages teams to ask “why” up to five times to uncover underlying causes.
    • Fishbone Diagram: Effective in exploring multiple causes across various categories. It is particularly useful when symptoms appear complex and multifactorial.
    • Fault Tree Analysis: Suitable for more quantitative issues or where complex failures need to be broken down systematically. Ideal for evaluating operational processes and identifying failure pathways.

    Understanding the context and complexity of your issues will guide the selection of the most appropriate tool for effective root cause identification.

    CAPA Strategy (correction, corrective action, preventive action)

    Once root causes have been identified, developing a robust CAPA strategy is essential:

    • Correction: Address immediate failures by conducting additional drop tests on remaining stock and verifying integrity evaluations for already sold products, as necessary.
    • Corrective Action: Implement necessary procedural changes, such as additional training for personnel handling the new valves, revising standard operating procedures (SOPs), or conducting supplier re-evaluation.
    • Preventive Action: Establish a more stringent change control process to evaluate future supplier changes. This may include pre-qualification of suppliers and validation of new materials in pilot runs before full-scale production.

    Carefully documenting each action will facilitate compliance with regulatory standards and improve future operational procedures.

    Control Strategy & Monitoring (SPC/trending, sampling, alarms, verification)

    Following the implementation of CAPA, a robust control strategy should be introduced:

    Related Reads

    • Statistical Process Control (SPC): Reinforce the use of SPC to monitor production parameters, ensuring any deviations are detected early.
    • Sample Testing: Increase sample sizes for drop testing and establish trigger points for corrective actions if thresholds are exceeded.
    • Alarms and Alerts: Setup alarms for critical operations associated with valve integrity, establishing a proactive response mechanism.
    • Verification Procedures: Regularly verify the effectiveness of implemented controls through internal audits and evaluations.

    Establishing a continuous monitoring system will enable quicker responses to any signs of future deviations.

    Validation / Re-qualification / Change Control impact (when needed)

    Changes to suppliers may also necessitate various validation activities, depending on the impact of those changes:

    • Validation Activities: Review and potentially re-validate manufacturing processes which may have changed due to new valve specifications.
    • Change Control Process: If the change results in significant process alterations, a formal change control process should be performed to assess the impact and ensure compliance.
    • Re-qualification: Depending on the severity of the issue, consider re-qualifying the equipment and processes involved.

    Maintaining compliance with regulatory expectations is critical for sustaining product quality and ensuring patient safety.

    Inspection Readiness: what evidence to show (records, logs, batch docs, deviations)

    Having organized and readily available documentation is key during inspections:

    • Deviation Records: All recorded deviations related to the drop test failure must be easily accessible.
    • Employee Training Records: Documented proof of training for personnel in proper protocols with respect to the new valve must be available.
    • Batch Documentation: Ensure that complete batch records, including testing results and corrective measures taken, are well-maintained.
    • Supplier Qualification Documentation: Maintain records for all supplier evaluations and changes, linking such changes to risk assessments performed.

    Preparedness with these documents will not only enhance regulatory compliance but also contribute to an organization’s overall quality assurance culture.

    FAQs

    What is a drop test in pharmaceutical manufacturing?

    A drop test evaluates the integrity of packaging by subjecting it to simulated impacts that could occur during transport.

    Why did the valve supplier change impact drop testing?

    Valve material or design differences may affect sealing integrity, resulting in packaging that does not withstand standard drop tests.

    What immediate actions should be taken after a drop test failure?

    Immediate actions include quarantining affected batches, notifying stakeholders, and performing additional testing on potentially affected products.

    What are the root cause analysis tools?

    Root cause analysis tools include the 5-Why analysis, Fishbone diagrams, and Fault Tree Analysis, each serving different complexity of investigations.

    How do I implement a CAPA strategy?

    A CAPA strategy should include immediate corrections, identifying corrective actions, and establishing preventive actions to mitigate future failures.

    What is the importance of change control in pharmaceutical manufacturing?

    Change control helps manage alterations in processes or suppliers to minimize risks associated with product quality and compliance.

    What should documents should I prepare for an inspection?

    Prepare deviation records, employee training logs, batch documentation, and supplier qualification documentation for inspection readiness.

    How often should I conduct a risk assessment when changing suppliers?

    Risk assessments should be conducted for each change, particularly when a supplier change impacts critical components of a product.

    What is the significance of statistical process control (SPC)?

    SPC helps in monitoring and controlling manufacturing processes, ensuring that all products remain within specified quality limits.

    What ongoing monitoring may be required after a CAPA strategy is implemented?

    Ongoing monitoring may include regular audits, increased sample testing, and continual training to ensure sustained compliance and product quality.

    Pharma Tip:  Improving Recyclability of Aerosol Packaging Materials